Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy.

Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy. Abstract Text:

    minyi guMinyi Gu,rosemary wiltonRosemary Wilton,fred j stevensFred J Stevens,

    BACKGROUND/AIMS: Primary amyloidosis and the cancer, multiple myeloma, are characterized by the overproduction of free antibody light chains. Approximately 10% of myeloma patients develop amyloidosis; primary amyloidosis may be thought of as the pathological analog of monoclonal gammopathy of undetermined significance. The kidney is a common site of accumulation of amyloid fibrils and is also the target of other light chain pathologies. Understanding the structural origin of these pathologies is complicated by the extreme primary structure heterogeneity of light chains. METHODS: Patterns of light chain germline gene usage in myeloma patients were compared to those found in other immune system disorders: lymphoma, leukemia, systemic lupus erythematosus and rheumatoid arthritis. RESULTS: Significant differences in apparent gene usage are found in the various diseases; several germline gene products have not been documented in myeloma patients to date. CONCLUSION: The plasma cell dyscrasias including myeloma, lymphoma, leukemia, and monoclonal gammopathy of undetermined significance are usually monoclonal diseases; however, the light chains produced are not homogeneous. Thus, the pathological risk for the patient may change during the course of the illness. Mutation rates in light chains observed during clonal diversification parallel mutations occurring in all genes in the malignant cells and could be a clinically useful biomarker.

    Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy. Publishing Authors By Initials

    m guM Gu,r wiltonR Wilton,fj stevensFJ Stevens,

    For similar genetic phenomena: variation (genetics) research abstracts see: genetic phenomena: variation (genetics) research

    PUBMED ID PMID:

    MEDLINE DATE:

    Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy. Journal Published:

    PUBLICATION TYPE: Review

    Journal: Contributions to nephrology

    VOLUME: 153

    Page Numbers: 156-81

    Journal Abbreviation:

    ISSN: 0302-5144

    DAY: 3

    MONTH: 12

    YEAR: 2007

    Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7513582

    Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy. Keywords Mesh Terms:

    KEYWORDS: Variation (Genetics)

    MESH TERMS: immunology

    Chemical & Substance for Abstract: Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy. Information

    Substance Name: DNA

    Registry Number: 9007-49-2

    Grant and Affiliation Information for Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy.

    AFFILIATION: Biosciences Division, Argonne National Laboratory, Argonne, IL 60439, USA.

    Country: Switzerland

    Switzerland Research PublicationSwitzerland Research Publication

    AGENCY: United States NIDDK

    GRANT: DK43957

    ACRONYM: DK

    MEDLINETA: Contrib Nephrol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News